ImmunityBio, Inc. — Director's Dealing 2019

Jun 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2019-06-06

Reporting Person: Thomas John C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-06	Common Stock	A	92592	$0.00	Acquired	394069	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13886	Indirect

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of NantKwest, Inc. common stock.

F2: Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of June 6, 2020 or the date immediately preceding the 2020 annual meeting of stockholders.

F3: Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96